Clinical trial
Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects
NCT06507787 is registered in ClinicalTrials.gov with Alcediag as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects
- Lead sponsor
- Alcediag
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 3, 2025
- Completion date
- May 31, 2027
- Enrollment
- 450 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.